The expression of the low-affinity NGF receptor (p75) and the trkA proto-oncogene product was analyzed in a series of human hematopoietic cell lines at protein and RNA levels. We did not detect any form of NGF receptor in cell lines displaying a myelomonocytic phenotype (HL60 and U937). In contrast, cells displaying a more immature erythroleukemic phenotype (TFI and K562) expressed TrkA in the absence of detectable p75. Scatchard analysis showed a single high-affinity site for NGF /kd = 10"" mol/L), with a copy number ranging from 300 to 3,000 sites per cell depending on the studied cell line. In addition, NGF induced autophosphorylation of TrkA and could substitute for granulocyte-monocyte colony-stimulating factor to trigger the HE PROLIFERATION and the differentiation of hematopoietic stem cells is regulated by a series of polypeptide growth factors referred to as colony-stimulating factors (CSFs) and interleukins (ILs).' The successive action of these mediators on bone marrow precursor cells allows for their maturation into functional blood cells. Recent studies have characterized the receptors of numerous cytokines involved in these processes and defined a family of molecules defined as cytokine receptors, which share some conserved motifs' as well as having functional ~imilarities.~ Besides the cytokine receptor family, receptor tyrosine kinases encoded by thefms proto-oncogene (macrophage-CSF [M-CSF] rec e p t o~)~ and kit proto-oncogene (stem cell factor receptor)5 also transduce important signals for hematopoietic cell maturation.
HE PROLIFERATION and the differentiation of hematopoietic stem cells is regulated by a series of polypeptide growth factors referred to as colony-stimulating factors (CSFs) and interleukins (ILs).' The successive action of these mediators on bone marrow precursor cells allows for their maturation into functional blood cells. Recent studies have characterized the receptors of numerous cytokines involved in these processes and defined a family of molecules defined as cytokine receptors, which share some conserved motifs' as well as having functional ~imilarities.~ Besides the cytokine receptor family, receptor tyrosine kinases encoded by thefms proto-oncogene (macrophage-CSF [M-CSF] rec e p t o~)~ and kit proto-oncogene (stem cell factor receptor)5 also transduce important signals for hematopoietic cell maturation.
In addition to the classical CSFs and ILs, some other cytokines also display discrete hematopoietic stimulating activities. This is the case for NGF, classically known for its activity on the survival, development, and maintenance of embryonic peripheral sympathetic and sensory neurons, and also identified as a neurotrophic factor for some central neurons.6 More recently, it has been shown that injections of NGF into neonatal rats result in a significant increase of tissue mast cell number, and that NGF promotes mainly eosinophil and basophil/mast cell colony formation in semisolid medium culture conditions in vitro.7" I Human and rat NGF receptors were initially cloned, with the help of monoclonal antibodies (MoAbs) recognizing a 75-kD protein (hereon p75) expressed on the surface of neural crest-derived cells.12.13 However, transfection in eukaryotic cells of plasmids encoding this molecule led to the expression of putative receptors displaying only a low affinity for NGF, with a dissociation constant in the range of lo-* to IO-' mol/L. In addition to p75, another molecule identified as the trk proto-oncogene product also binds NGF,'"l6 The trk oncogene (tropomyosin receptor kinase) was originally identified as a transforming gene from a human colon carcinoma, formed by a fusion between tropomyosin and a tyrosine kinase.",'* trkB and ~rkC,~'-" genes closely related to trk (hereon trkA), encode protein tyrosine kinases that serve as receptors for the NGF-related ligands: brain&- proliferation of the TFI cell line, with a half-maximal signal observed at 50 pmol/L, indicating that p75 is not required for DNA synthesis in this cell line. The physiologic relevance of NGF in early hematopoiesis was confirmed by showing that 12% to 15% of progenitor blood cells from mice treated with 5-fluorouracil expressed TrkA and that these cells could be induced to proliferate and differentiate in response to NGF in association with macrophage colonystimulating factor. Our study demonstrates for the first time that rrkA proto-oncogene expression and activation is not restricted to the nervous system, but is also an important element in early hematopoiesis. rived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4).25-2y Binding of NGF to TrkA induces its autophosphorylation as well as subsequent signaling events inside the cell. Binding studies for NGF and TrkA have produced conflicting results depending on the investigators. In some experiments, TrkA by itself displayed a high-affinity binding site for NGF (10"' to lo-" mol/L) and was sufficient for cellular signal transd~ction.'~ In other systems, TrkA, as p75, only exhibited a low affinity for the ligand, and a coexpression of both TrkA and p75 was required for the formation of a functional receptor with a high affinity for N G F .~~
The differentiation and proliferation of progenitors from bone marrow to mature mast cells is driven by several cytokines belonging to the CSF and IL family. This property is shared by IL-3, IL-4, IL-9, granulocyte-macrophage CSF (GM-CSF), and stem cell factor.30 A puzzling correlation is the ability of the same growth factors to also behave as costimulating activities in hematopoietic stem cell assays, suggesting a direct relationship between hematopoietic stem cells and mature mast cells.30 Several reports have demonstrated the ability of NGF to act as a mast cell growth factor alone or in combination with GM-CSF."" These observations prompted us to analyze the effects of NGF on undifferentiated myeloid progenitors by using in vitro established tumor cell lines or stem cell primary cultures. ~l~rosinephosphor?~/u/ion us.suyr. Cells were starved for 60 minutes in defined medium and then treated with 50 ng/mL of each of the neurotrophins (NGF, BDNF, NT-3. or NT-4) for 5 minutes before lysis in RIPA buffer (phosphate-buffered saline [PBS] containing I % NP-40, O.I% sodium dodecyl sulfate [SDS] . 0.5% deoxycholate, l mmol/L phenylmethylsulfonyl fluoride, l mmol/L orthovanadate, and 0.14 U/mL aprotinin). The total lysates were then immunoprecipitated with purified pan-Trk-specific polyclonal antisera RG22, followed by an antirabbit secondary antibody conjugated to agarose. Tyrosine phosphorylation of the immunoprecipitated Trks was determined as described p r e v i o u~l y .~~ Binding ussa.~~.r. '251-labeled NGF was purchased from Amersham (Amersham, UK) (1.500 Ci/mmol). Binding assays were performed in PBS containing IO% fetal calf serum and 20 mmol/L HEPES. Cells ( I to 3 X IO6) were incubated with increasingconcentrations of radiolabeled NGF in a final volume of 50 pL. Nonspecific binding was evaluated by including a 100-fold excess of unlabeled ligand. After incubation under agitation for 2 hours at 4°C. cell-bound radioactivity was separated from the unbound fraction by centrifugation through a layer ofdibutylphtalate (90%) and paraffin oil ( 10%). Determination of affinity binding components was performed by nonlinear regression analysis of the binding data according to S~atchard.'~ Norrkrn hlors. A 0.8-kb EcoRI/EcoRI cDNA fragment encoding the extracellular portion of the low-affinity nerve growth factor receptos7 and a 1.2-kb BurnHI/EcoRI fragment containing sequences for the tyrosine kinase domain of the rrkA oncogene17 were Northern blot analysis of p75 and rrkA mRNA in neural and hematopoietic cells. Total RNA from SK-N-MC, K562, KG1, U937, SY5Y. and TF1 cell lines was prepared and equal amounts of glyoxal/DMSO denaturated RNA (approximately 50 pg) were electrophoresed on 1.5% agarose gels and transferred to membranes. Hybridizations were performed in 50% formamide, 5 X SSPE, 5 X Denhardt's solution, 0.5 mg/mL denatured salmon sperm a t 42'C using a 1.2-kb BamHI/€coRI fragment containing sequences for the tyrosine kinase domain of the trkA oncogene or a 0.8-kb EcoRl cDNA fragment encoding the extracellular portion of the low-affinity nerve growth factor receptor radiolabeled by random priming. Filters were washed to a final stringency of 0.2 X SSC. 0.5% SDS twice for 1 hour a t 54'C.
MATERIALS AND METHODS
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labeled by random priming and used for hybridization. Total RNA was prepared according to the method of Chomczynski and Sacchi.'* Equal amounts of glyoxal dimethyl sulfoxide (DMSO)-denaturated RNA (approximately 50 pg) were electrophoresed on I S % agarose gels and transferred to membranes (Hybond N; Amersham). Hybridizations were performed in 50% formamide, 5X SSPE, 5X Denhardt's solution. and 0.5 mg/mL denatured salmon sperm at 42°C. Filters were washed to a final stringency of0.2X SSC, 0.5% SDS twice for I hour at 54°C.
RESULTS
Expression of NGF receptors was analyzed at the mRNA level in a series of human hematopoietic cell lines. RNAs prepared from the cell lines were hybridized with probes recognizing the mRNAs coding for either p75 or TrkA proteins (Fig 1) . No mRNA encoding p75 could be detected in any tested hematopoietic cell lines, whereas transcripts were observed in the control neuroblastoma cell lines, SK-NMC and SY5Y. In contrast, a transcript of 3.2 kb was clearly detected with a frkA probe in the TFI and K562 cell lines and with lowered levels in the KG1 and SY5Y cell lines. Figure 2 shows that, in addition to detectable TrkA expression on the SY5Y neuroblastoma cell line. the MoAb recognizing TrkA also gave detectable signals with the TFI and K562 erythroleukemic cell lines, in agreement with the mRNA analysis. The low copy number of TrkA expressed by KG1 (see Scatchard analysis below) did not allow detection by cytofluorometry. In contrast, none ofthe hematopoietic cell lines screened in this analysis expressed p75. whereas significant expression was detected on control SK-N-MC neuroblastoma cells again. in agreement with the observations made at mRNA level.
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To determine whether TrkA expressed in erythroleukemia cells was able to initiate signal.transduction in response to NGF, we examined its ability to be inducibly tyrosine phosphorylated in response to NGF. Both K562 and TFI cellsdisplayed NGF-dependent tyrosine phosphorylation of a 140-kD protein that could be specifically immunoprecipitated using a Trk-specific antisera (Fig 3), indicating that TrkA, in the absence of p75, is capable of initiating signal transduction in response to NGF. As with TrkA expressed in other systems, this proto-oncogene was specifically activated in response to NGF but not with any of the other neurotrophins.
Binding experiments were next performed with increasing concentrations of radiolabeled NGF. Figure 4A shows a typical saturation curve obtained on the TFI cell line. Scatchard analysis of the experiment (Fig 4B) showed a single high-affinity binding site with a kd of 1 to 2 X 10"' mol/ L. Scatchard plots were linear with no evidence for biphasic binding such as is observed with PC12 cells (Table l) , which are known to coexpress TrkA in association with ~7 5 . '~ As summarized in Table I , the number of receptors expressed by the erythroleukemic cell lines varied from a few hundred copies per cell for the KG 1 cell line to 3,000 for the TFI cell line, with dissociation constants ranging from 1 to 3 X IO-"' mol/L. Two conclusions could be drawn from these analyses. Firstly, the expression of TrkA correlated with the cell lines displaying the more immature phenotype of erythro-
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-TrkA The total lysates were then immunoprecipitated with purified pan-Trkspecific polyclonal antisera RG22, followed by an antirabbit secondary antibody conjugated to agarose. Tyrosine phosphorylation of the immunoprecipitated Trks was determined by using an antiphosphotyrosine antibody.
For leukemia, because no transcript for trkA or protein expression could be detected in the more mature myelomonocytic U937 and HL60 cell lines. Furthermore, in contrast to the situation observed in the nervous system in which the lowaffinity component of the NGF receptor is usually more abundantly expressed than the trkA proto-oncogene product,"j we could not detect p75 in any of the cell lines of hematopoietic origin.
CHEVALIER ET AL
The in vitro growth dependency of TF1 cells on exogenously added cytokines (such as IL-3 or GM-CSF) provided an opportunity to test the functional ramifications of TrkA activation by NGF in hematopoietic cells. Using a 2-day colorimetric assay, NGF triggered TFl cell proliferation with a half-maximal effect at approximatively 1 ng/mL NGF (yielding a specific activity for NGF of lo6 U/mg in this assay). When compared with GM-CSF for its proliferative effect, NGF was half as potent (Fig 5) . The NGF effect, but not the GM-CSF effect, was completely abrogated by an MoAb specifically capable of blocking NGF action. In addition, long-term growth of TFl cells, for more than 3 months, could be maintained in the presence of 10 ng/mL NGF. This long-term growth in NGF occurred without any decrease in the doubling time of the TFI cells (24 to 30 hours) and did not result in the emergence of a terminal differentiation process (data not shown).
Taken together, the above data clearly show that TrkA is expressed by and mediates functional responses to NGF in immature hematopoietic cell lines, raising the possibility that NGF displays a hematopoietic stem cell activity in vivo. To test this hypothesis, enriched mouse precursor bone marrow cells were collected from mice treated for 60 hours with 5-fluorouracil. In these conditions, 12% to 15% of the enriched precursor bone marrow cells were positively stained by intracytoplasmic immunofluorescence using a polyclonal antibody specific for TrkA (Santa Cruz Biotechnology, Santa Cruz, CA) (data not shown). Bone marrow cells from 5-fluorouracil-treated mice were then plated in semisolid medium and exposed during 14 days to various combinations of cytokines, as shown in Table 2 . Proliferation and differentiation of early progenitor cells from 5-fluorouracil-treated animals requires the synergistic action of at least 2 cytokines, such as IL-1 and M-CSF.34 As shown in Table 2 , NGF by itself could not trigger early progenitor cell growth and differentiation. However, the factor can substitute for IL-1 to generate colony formation in the presence of M-CSF. Under these conditions, two types of colonies were observed based on phenotypic and morphologic criteria: high proliferative potential colony-forming units (HPP-CFU), which are macroscopic colonies emerging from very primitive progenitor cells, and granulocyte-monocyte colony-forming units (GM-CFU).34 In our culture system, we did not detect the presence of mast cell in the GM-CFLJ colonies as reported in other studies." These results clearly indicate that NGF can act as a costimulating signal for the proliferation and differentiation of the early hematopoietic progenitor cells present in mouse bone marrow.
DISCUSSION
Recent studies have shown that the p75 low-affinity NGF receptor shares some homology with a family of membrane 1403 proteins, including tumor necrosis factor receptors type I and I1 and the CD40 antigen,"" which play important roles in the immune response. In addition, a receptor referred to as gp140, which is the product of the trkA protooncogene, also binds NGF and constitutes a second class of NGF recept~r.'~.'~ To investigate the possible presence and nature of NGF receptors in cells of myeloid lineage, we used MoAbs recognizing both types of NGF receptors. Major signals were detected on the surface of erythroleukemic cell lines, which are phenotypically related to early myeloid progenitors. In none of the cell lines tested so far could we detect the expression of p75, either by Northern blot analysis or by immunologic labeling with an MoAb. These observations show that binding of NGF to erythroleukemic cell lines does not involve p75 or that its expression level is very low and is thus below the level of detection of the methods used. In striking contrast, a clear expression of trkA mRNA and TrkA protein was detectable in TFI, K562, and KG1 erythroleukemic cell lines. A trkA transcript had previously been detected in the hematopoietic line K562, but no protein expression or functional response could be associated to this observation (Martin-Zanka et alla and D. Martin-Zanca, personal communication). Equilibrium binding analysis of NGF on these erythroleukemia cell lines showed a single dissociation constant in the range of 10"' mol/L, in accordance with the idea that a single class of binding sites is present on these cells.
TrkA/NGF receptor in TF1 cells is fully functional because NGF is able to induce its autophosphorylation and also to trigger the proliferation of the TF1 cell line in picomolar concentrations in the absence of p75 expression, suggesting that the low-affinity component of NGF receptor binding is not necessary in this system. In line with this observation, the survival and differentiation of the neuronal MAH cell line in response to NGF, when the cells are induced to express TrkA, in the absence of p75, has been reported.42 Similarly, site-directed mutagenesis of the NGF For personal use only. on October 3, 2017. by guest www.bloodjournal.org From molecule suggests that NGF-induced differentiation of chick embryo ganglia does not require interaction of the ligand with ~7 5 .~~ Furthermore, it has recently been shown that genetically engineered 3T3 fibroblast-expressing Trk family members can be induced to proliferate in the presence of the appropriate neurotrophin, providing indirect evidence that, in addition to their maintenance and differentiation effects in nerve tissues, the Trk/neurotrophin interaction may mediate proliferation phenomena.'5s'9,2' As reported here, the proliferative response of the TF I cell line to NGF clearly demonstrates that trkA proto-oncogene activation, like that of many other tyrosine kinase recept o r~, '~.~~ can trigger an effective mitogenic response and cell proliferation in a nontransfected biologic system. It would now be of considerable interest to introduce p75 into these erythroleukemia cells to investigate the effect of the lowaffinity NGF binding component on the proliferation/ differentiation balance and phosphorylation level of TrkA.
A role for NGF in the terminal differentiation of mastocytes has been suggested by several g r o~p s .~. '~ Our study shows for the first time that NGF also plays a role in early hematopoiesis. 5-Fluorouracil treatment of mice induces an enrichment of noncyclic hematopoietic stem cells that can next be committed to proliferate and differentiate with a combination of at least two factors,34 one of them acting as a cycling signal (IL-1) and the second one as a progression signal (GM-CSF, M-CSF, or IL-3). Our results show that NGF is able to replace IL-1 as a cycling signal to stimulate colony development in vitro, suggesting that this classical neurotrophic factor may influence the development fate of a wide spectrum of hematopoietic cells. In addition to this work, we have looked for the protein expression of TrkA and p75 in freshly isolated human thymocytes, spleenocytes, peripheral blood leukocytes, and total bone marrow cells. In all the tested tissues we failed to detect any form of NGF receptor. Interestingly, a limited subset of cells representing 5% to 10% of CD34+ purified progenitors from human bone marrow was stained with the MoAb antiTRKa (unpublished observation). Taken together, these observations reinforce the notion of a restricted expression of trkA to a very defined subset of hematopoietic cells.
We have recently reported that ciliary neurotrophic factor, like NGF, can also act outside the nervous system and, in association with a soluble form of its receptor, is able to elicit biologic responses in hematopoietic cells expressing the leukemia inhibitory factor receptor.45 In a reciprocal manner, it has been suggested that several immune regulators, including IL-5, IL-7, IL-9, and IL-l I , have an important influence on the biology of hippocampus-derived neuronal cells.46 Taken together, these observations demonstrate an effective synergism between neurotrophin and interleukin family members in both the nervous and immune systems. The influence of the other members of the neuronal growth factor family (BDNF, NT-3, and NT-4) in the hematopoietic system should give new insights into the biology of the neurotrophins.
In conclusion, we have shown that the function of the trkA proto-oncogene pathway is not only restricted to neural tissue but is also effective in early hematopoiesis. Association of TrkA with its ligand constitutes, along with the kit and,fms proto-on~ogenes,~.~ a new example of a tyrosine kinase receptor implicated in hematopoiesis. Moreover, our observations suggest that analysis of the cells expressing 
